They can still make 80-90% gross margin and the EBITDA will depend on marketing push," said Manchanda
Patients on SheMed's programme who were previously snacking multiple times a day, which was around 40% of users before they started, dropped to well under 10% by their first refill
Thats still significantly less than the $1,349 list price, but its a different program with different pricing
& Geiger, K
Judicial Panel on Multidistrict Litigation issued a transfer order on February 2, 2024, instructing all GLP-1 stomach paralysis lawsuits involving Ozempic, Wegovy, Mounjaro and other similar GLP-1 drugs to be centralized in the U.S
In such patients, additive reductions in blood pressure could potentially lead to hypotension, particularly during the dose-escalation phase